MedTrace Logo

Polyacrylate Polyalcohol Copolymer for Vesicoureteral Reflux

NCT01926353 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2015-04-07

No results posted yet for this study

Summary

Endoscopic correction of VUR has gained its popularity due to its less invasiveness, associated low morbidity and short hospital stay. Although short term follow-up had justified their efficacy; however, long term recurrence and complications following endoscopic correction were also being reported in the literatures (6). Currently, there are insufficient evidences on the efficacy and safety of biocompatible tissue augmenting materials used for endoscopic correction of VUR; particularly on the new tissue bulking agents. (6) Polyacrylate polyalcohol copolymer (PPC)-Vantris ® (Promedon, Cordoba, Argentina) is the newest tissue augmenting biocompatible Acrylics used for endoscopic correction of VUR.

Conditions

Sponsors & Collaborators

  • St. Luke's Medical Center, Philippines

    lead OTHER

Principal Investigators

  • Marcelino L Morales, MD · Institute of Urology, St. Luke's Medical Center, Quezon City, Philippines

Eligibility

Min Age
1 Year
Max Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • Philippines

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01926353 on ClinicalTrials.gov